Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoNTRST: Travasol for Prevention of Contrast Nephropathy
NCT00313807Phase 2Withdrawn
- Sponsor
- Queen's University
- Start
- Nov 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Travesol in contrast-associated nephropathy (CA-AKI), sponsored by Queen's University. Planned start Nov 2005; status: withdrawn.
02
Drugs
Travesol
03
Conditions
contrast-associated nephropathy (CA-AKI)
Beyond the preview
Go deeper on NCT00313807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00313807.